These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24434362)

  • 1. Diagnosis and classification of IgA nephropathy.
    Yu HH; Chiang BL
    Autoimmun Rev; 2014; 13(4-5):556-9. PubMed ID: 24434362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA Nephropathy: Core Curriculum 2021.
    Pattrapornpisut P; Avila-Casado C; Reich HN
    Am J Kidney Dis; 2021 Sep; 78(3):429-441. PubMed ID: 34247883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and monitoring of IgA nephropathy: the role of biomarkers as an alternative to renal biopsy.
    Moresco RN; Speeckaert MM; Delanghe JR
    Autoimmun Rev; 2015 Oct; 14(10):847-53. PubMed ID: 26026694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
    Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges.
    Gutiérrez E; Carvaca-Fontán F; Luzardo L; Morales E; Alonso M; Praga M
    Nephron; 2020; 144(11):555-571. PubMed ID: 32818944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
    Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
    Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining.
    Ştefan G; Ismail G; Stancu S; Zugravu A; Andronesi A; Mandache E; Mircescu G
    Pathol Int; 2016 Aug; 66(8):453-9. PubMed ID: 27439692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
    Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury.
    Andeen NK; Jefferson JA; Akilesh S; Alpers CE; Bissonnette ML; Finn LS; Higgins J; Houghton DC; Kambham N; Magil A; Najafian B; Nicosia RF; Troxell ML; Smith KD
    Hum Pathol; 2018 Nov; 81():272-280. PubMed ID: 30420049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
    Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
    Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
    Sofue T; Suzuki H; Ueda N; Kushida Y; Minamino T
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic role of IgA receptors in IgA nephropathy.
    Monteiro RC
    Contrib Nephrol; 2007; 157():64-9. PubMed ID: 17495439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of intensity, localization and type of deposits in renal biopsy for disease symptoms and follow up in children with IgA nephropathy].
    Cichoń-Kawa K; Mizerska-Wasiak M; Małdyk J; Turczyn A; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Sikora P; Gadomska-Prokop K; Grenda R; Pańczyk-Tomaszewska M
    Pol Merkur Lekarski; 2018 Apr; 44(262):177-182. PubMed ID: 29775444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenesis of IgAN.
    Barratt J; Smith AC; Molyneux K; Feehally J
    Semin Immunopathol; 2007 Nov; 29(4):427-43. PubMed ID: 17851660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic Classification of IgA Nephropathy: Past, Present, and Future.
    Soares MFS; Roberts ISD
    Semin Nephrol; 2018 Sep; 38(5):477-484. PubMed ID: 30177019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
    Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.
    He JW; Zhou XJ; Lv JC; Zhang H
    Theranostics; 2020; 10(25):11462-11478. PubMed ID: 33052226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pathogenesis of IgA nephropathy.
    Floege J; Moura IC; Daha MR
    Semin Immunopathol; 2014 Jul; 36(4):431-42. PubMed ID: 24442210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathogenic role for secretory IgA in IgA nephropathy.
    Oortwijn BD; van der Boog PJ; Roos A; van der Geest RN; de Fijter JW; Daha MR; van Kooten C
    Kidney Int; 2006 Apr; 69(7):1131-8. PubMed ID: 16395264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of glomerular deposition of nephritogenic IgA.
    Yamaji K; Suzuki Y; Suzuki H; Satake K; Horikoshi S; Novak J; Tomino Y
    PLoS One; 2014; 9(11):e113005. PubMed ID: 25409466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.